NCT00496392View on ClinicalTrials.gov

Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain (FT-019-IM)

PHASE3CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

October 31, 2009

Conditions
Pain
Interventions
DRUG

Nasal fentanyl

Breakthrough pain in patients with breast or prostate cancer

Trial Locations (1)

4000

Nycomed, Roskilde

Sponsors

Lead Sponsor

Nycomed
All Listed Sponsors
lead

Nycomed

INDUSTRY